Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00040586
Status:
COMPLETED
Last Update Posted:
2007-01-22
First Post:
2002-07-01
Brief Title:
Phase II Trial of Monoclonal Antibody J591 in Combination With Low-Dose Subcutaneous Interleukin-2
Sponsor:
BZL Biologics
Organization:
BZL Biologics
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2002-07-01
First Submit QC Date:
July 1 2002
Study First Post Date:
2002-07-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-01-19
Last Update Post Date:
2007-01-22
Last Update Post Date Type:
ESTIMATED